Mycenax Biotech Inc.
Research Mycenax Biotech Inc. (4726.TWO) on Bullrun: market cap TWD 4.80B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4726.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 4.80B
- Financial periodQ2 2026
- RevenueTWD 203.09M
- Net income-TWD 82.59M
- Free cash flowTWD 105.90M
- Gross margin-9.0%
Valuation Snapshot
latest market cap is TWD 4.80B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 4.80B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Mycenax Biotech Inc.
Mycenax Biotech Inc. provides biopharmaceutical services and solutions for drug development and production in Taiwan. The company's services include program evaluation/confirmation, cell line development and construction, process development technology platforms, drug characterization analysis, establishment of testing methods, and PIC/S GMP drug production. It offers CDMO services, including integrated biologics development services, specialized modalities, manufacturing, and quality services.
ETFs that hold Mycenax Biotech Inc.
US-listed ETFs
Mycenax Biotech Inc. is held by 3 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.02% | 0.65% |
| State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) | 0.02% | 0.19% |
Portfolios as filed with the SEC on Form N-PORT, dated June to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mycenax Biotech Inc.'s market cap?
Mycenax Biotech Inc.'s market capitalization is TWD 4.80B.
What does Mycenax Biotech Inc. do?
Mycenax Biotech Inc. provides biopharmaceutical services and solutions for drug development and production in Taiwan. The company's services include program evaluation/confirmation, cell line development and construction, process development technology platforms, drug characterization analysis, establishment of testing methods, and PIC/S GMP drug production. It offers CDMO services, including integrated biologics development services, specialized modalities, manufacturing, and quality services.